(ZSRI) BNP Paribas Easy MSCI - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1753045415

ZSRI: Equity, Securities, Investments, Europe, Large-Cap

The BNP Paribas Easy MSCI Europe SRI S-Series PAB 5% Capped UCITS ETF Distribution is an exchange-traded fund listed on XETRA under the ticker symbol ZSRI. As a Europe Large-Cap Blend Equity ETF, it is designed to track the Morningstar Developed Markets Europe index, providing investors with exposure to a broad range of European large-cap stocks.

From a technical analysis perspective, the ETFs price is currently at €29.27, slightly below its 20-day simple moving average (SMA) of €29.69, indicating a potential short-term downtrend. However, it remains above its 50-day SMA of €28.62 and 200-day SMA of €28.30, suggesting a longer-term uptrend. The average true range (ATR) is €0.19, representing a daily price volatility of 0.65%. Given these indicators, a potential trading strategy could involve monitoring the ETFs price movement in relation to its SMAs and adjusting positions accordingly.

Fundamentally, the ETF has a significant asset under management (AUM) of €1448.57 million, indicating a substantial investor base and liquidity. The funds focus on European large-cap stocks with a SRI (Sustainable and Responsible Investment) filter aligns with the growing trend of ESG (Environmental, Social, and Governance) investing. This could attract investors seeking to balance financial returns with sustainability considerations.

Forecasting the ETFs future performance involves analyzing both technical and fundamental data. Given the current technical indicators and the fundamental strength of the ETF, a potential forecast could involve a moderate increase in price as the ETF continues to track its underlying index and benefits from its diversified portfolio. If the 52-week high of €29.91 is breached, it could signal further upside potential. Conversely, a drop below the 52-week low of €25.24 could indicate a significant downturn. Therefore, investors should closely monitor the ETFs price movements and adjust their strategies based on the evolving technical and fundamental landscape.

Additional Sources for ZSRI ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

ZSRI ETF Overview

Market Cap in USD 1,699m
Category Europe Large-Cap Blend Equity
TER 0.25%
IPO / Inception 2018-03-13

ZSRI ETF Ratings

Growth Rating 63.1
Fundamental -
Dividend Rating 60.4
Rel. Strength -7.89
Analysts -
Fair Price Momentum 28.64 EUR
Fair Price DCF -

ZSRI Dividends

Dividend Yield 12m 3.25%
Yield on Cost 5y 4.99%
Annual Growth 5y 4.87%
Payout Consistency 86.8%
Payout Ratio %

ZSRI Growth Ratios

Growth Correlation 3m 67.1%
Growth Correlation 12m 62.3%
Growth Correlation 5y 81.6%
CAGR 5y 9.22%
CAGR/Max DD 5y 0.35
Sharpe Ratio 12m 0.77
Alpha -2.63
Beta 0.483
Volatility 12.38%
Current Volume 0.7k
Average Volume 20d 1.5k
What is the price of ZSRI shares?
As of July 01, 2025, the stock is trading at EUR 29.13 with a total of 679 shares traded.
Over the past week, the price has changed by +0.80%, over one month by -1.62%, over three months by +3.79% and over the past year by +6.98%.
Is BNP Paribas Easy MSCI a good stock to buy?
Yes. Based on ValueRay´s Analyses, BNP Paribas Easy MSCI (XETRA:ZSRI) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 63.09 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ZSRI is around 28.64 EUR . This means that ZSRI is currently overvalued and has a potential downside of -1.68%.
Is ZSRI a buy, sell or hold?
BNP Paribas Easy MSCI has no consensus analysts rating.
What are the forecasts for ZSRI share price target?
According to our own proprietary Forecast Model, ZSRI BNP Paribas Easy MSCI will be worth about 32.1 in July 2026. The stock is currently trading at 29.13. This means that the stock has a potential upside of +10.3%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 32.1 10.3%